南國置業(002305.SZ):擬設立18.1億元申萬宏源-電建南國疫後重振資產支持專項計劃
格隆匯10月26日丨南國置業(002305.SZ)宣佈,公司為繼續盤活存量資產和加快資金回籠,促進疫後重振,提高資產運營效率,擬以公司全資子公司湖北森南持有的泛悦匯曇華林項目進行資產證券化運作,公司聘請申萬宏源作為銷售機構和管理人設立“申萬宏源-電建南國疫後重振資產支持專項計劃”。該次專項計劃擬發行規模預計合計人民幣18.1億元,期限不超過5年。
該專項計劃的資產支持證券分為優先A級資產支持證券、優先B級資產支持證券、權益級資產支持證券。專項計劃成立後,優先級資產支持證券將在證券交易所掛牌交易。公司擬通過認購2.7億元權益級基金份額方式持有權益級資產支持證券,最終認購金額將根據深交所後續審批及專項計劃發行情況確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.